IperionX Valuation
Is 30Z undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 30Z when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 30Z (€2.82) is trading below our estimate of fair value (€33.2)
Significantly Below Fair Value: 30Z is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 30Z?
Key metric: As 30Z is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is 30Z's PB Ratio? | |
|---|---|
| PB Ratio | 16.4x |
| Book | US$51.34m |
| Market Cap | US$842.66m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | -36.1x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does 30Z's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.2x | ||
SZG Salzgitter | 0.2x | 93.9% | €942.2m |
STO3 Sto SE KGaA | 1x | 3.5% | €723.6m |
TKA thyssenkrupp | 0.2x | 126.6% | €2.4b |
ACT AlzChem Group | 3.2x | 12.6% | €606.5m |
30Z IperionX | 16.4x | 67.8% | €1.3b |
Price-To-Book vs Peers: 30Z is expensive based on its Price-To-Book Ratio (16.4x) compared to the peer average (1.2x).
Price to Book Ratio vs Industry
How does 30Z's PB Ratio compare vs other companies in the European Metals and Mining Industry?
| 23 Companies | Price / Book | Estimated Growth | Market Cap |
|---|---|---|---|
| 23 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Book vs Industry: 30Z is expensive based on its Price-To-Book Ratio (16.4x) compared to the European Metals and Mining industry average (0.9x).
Price to Book Ratio vs Fair Ratio
What is 30Z's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 16.4x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate 30Z's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €2.82 | €3.10 +10.1% | 4.3% | €3.23 | €2.97 | n/a | 2 |
| Nov ’25 | €2.08 | €2.67 +28.5% | 7.2% | €2.86 | €2.47 | n/a | 2 |
| Oct ’25 | €2.09 | €2.28 +9.2% | 6.7% | €2.44 | €2.13 | n/a | 2 |
| Sep ’25 | €1.63 | €2.24 +37.2% | 3.2% | €2.31 | €2.17 | n/a | 2 |
| Aug ’25 | €1.40 | €2.27 +62.0% | 2.4% | €2.32 | €2.21 | n/a | 2 |
| Jul ’25 | €1.35 | €2.29 +69.4% | 3.2% | €2.36 | €2.21 | n/a | 2 |
| Jun ’25 | €1.45 | €2.29 +57.7% | 3.2% | €2.36 | €2.21 | n/a | 2 |
| May ’25 | €1.26 | €2.20 +74.5% | 1.2% | €2.22 | €2.17 | n/a | 2 |
| Apr ’25 | €1.35 | €2.20 +62.8% | 1.2% | €2.22 | €2.17 | n/a | 2 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
UBE
JP¥237.9b
Engages in the chemicals, construction materials, and machinery businesses in Japan, North America, Europe, Africa, the Middle East, Thailand, India, Latin America, and internationally.
UBE
JP¥15.00
7D
6.4%
1Y
5.6%
Ecora Resources
UK£162.5m
Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.
HGR
UK£0.76
7D
-1.4%
1Y
-29.4%
Stanmore Resources
AU$2.8b
Engages in the exploration, development, production, and sale of metallurgical coal in Australia.
S0D
AU$1.91
7D
2.1%
1Y
-15.5%